A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B-Reference-Cited by-同舟云学术

A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B

Published:2023-05 Issue:5 Volume:78 Page:926-936
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

van Bömmel Florian^ORCID,Stein Kerstin,Heyne Renate,Petersen Jörg,Buggisch Peter,Berg Christoph,Zeuzem Stefan,Stallmach Andreas,Sprinzl Martin,Schott Eckart,Pathil-Warth Anita,von Arnim Ulrike,Keitel Verena,Lohmeyer Jürgen,Simon Karl-Georg^ORCID,Trautwein Christian,Trein Andreas,Hüppe Dietrich,Cornberg Markus,Lammert Frank^ORCID,Ingiliz Patrick^ORCID,Zachoval Reinhart,Hinrichsen Holger,Zipprich Alexander^ORCID,Klinker Hartmuth,Schulze zur Wiesch Julian,Schmiedeknecht Anett,Brosteanu Oana,Berg Thomas^ORCID

Publisher

Elsevier BV

Subject

Hepatology

Reference34 articles.

1. World Health Organization. Hepatitis B. Fact sheet. Retrieved December 20, 2017, from https://www.who.int/mediacentre/factsheets/fs204/en/Accessed July 2017.

2. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection;Weinbaum;Hepatology,2009

3. Hepatitis B virus infection;Liaw;Lancet,2009

4. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection;Lampertico;J Hepatol,2017

5. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance;Terrault;Hepatology,2018

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kinetics and Value of Hepatitis B Core-Related Antigen in Patients with Chronic Hepatitis B Virus Infection during Antiviral Treatment;Viruses;2024-02-05

2. Hepatitis B Surface Antigen Kinetics After Tenofovir Withdrawal in Chronic Hepatitis B;American Journal of Gastroenterology;2024-02

3. Higher end‐of‐treatment HBsAg levels is associated with later onset but not severe relapse in HBeAg‐negative chronic hepatitis B patients stopping antivirals;Alimentary Pharmacology & Therapeutics;2024-01-18

4. Treatment cessation in HBeAg-negative chronic hepatitis B: clinical response is associated with increase in specific proinflammatory cytokines;Scientific Reports;2023-12-18

5. Letter: Estimating the incidence of HBsAg seroclearance after cessation of tenofovir and entecavir—potential influence of censored observation. Authors' reply;Alimentary Pharmacology & Therapeutics;2023-12-12